- Home
- OMGA vs IOBT Comparison
OMGA vs IOBT Comparison
Compare OMGA & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMGA
- IOBT
- Stock Information
- Founded
- OMGA 2017
- IOBT 2014
- Country
- OMGA United States
- IOBT Denmark
- Employees
- OMGA N/A
- IOBT N/A
- Industry
- OMGA Biotechnology: Pharmaceutical Preparations
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- OMGA Health Care
- IOBT Health Care
- Exchange
- OMGA Nasdaq
- IOBT Nasdaq
- Market Cap
- OMGA 53.6M
- IOBT 56.7M
- IPO Year
- OMGA 2021
- IOBT 2021
- Fundamental
- Price
- OMGA $0.55
- IOBT $0.84
- Analyst Decision
- OMGA Strong Buy
- IOBT Strong Buy
- Analyst Count
- OMGA 5
- IOBT 3
- Target Price
- OMGA $9.20
- IOBT $9.33
- AVG Volume (30 Days)
- OMGA 278.9K
- IOBT 203.5K
- Earning Date
- OMGA 11-14-2024
- IOBT 03-04-2025
- Dividend Yield
- OMGA N/A
- IOBT N/A
- EPS Growth
- OMGA N/A
- IOBT N/A
- EPS
- OMGA N/A
- IOBT N/A
- Revenue
- OMGA $8,095,000.00
- IOBT N/A
- Revenue This Year
- OMGA $181.38
- IOBT N/A
- Revenue Next Year
- OMGA N/A
- IOBT N/A
- P/E Ratio
- OMGA N/A
- IOBT N/A
- Revenue Growth
- OMGA 185.04
- IOBT N/A
- 52 Week Low
- OMGA $0.52
- IOBT $0.66
- 52 Week High
- OMGA $4.46
- IOBT $1.89
- Technical
- Relative Strength Index (RSI)
- OMGA 29.98
- IOBT 45.71
- Support Level
- OMGA $0.52
- IOBT $0.77
- Resistance Level
- OMGA $0.67
- IOBT $0.95
- Average True Range (ATR)
- OMGA 0.09
- IOBT 0.08
- MACD
- OMGA -0.02
- IOBT -0.01
- Stochastic Oscillator
- OMGA 5.95
- IOBT 22.16
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.